FMCSA Safety Initiatives Update Larry W Minor Associate

FMCSA Safety Initiatives Update Larry W. Minor Associate Administrator for Policy November 17, 2020

Drug & Alcohol Clearinghouse (December 5, 2016, Final Rule) l Motor carriers, Medical Review Officers (MROs), Substance Abuse Professionals (SAPs), and consortia/third party administrators (C/TPAs) to report: Verified positive, adulterated, and substituted drug test results, positive alcohol test results, test refusals, negative return-to-duty test results, and information on follow-up testing. l Motor carriers would be required to report actual knowledge of traffic citations for driving a commercial motor vehicle (CMV) while under the influence (DUI) of alcohol or drugs. l Compliance date: January 6, 2020. –

Clearinghouse (Continued) Reporting: – Employers/Service Agents report positive tests/refusals. – Employers must report actual knowledge of DUIs. – Labs must report annual summary of activity. l Searching: – Employers check pre-employment and annually for all drivers. – SDLAs check before issuing CDL. – NTSB access during crash investigation. l Retention: – Record removed after 5 years if return-to-duty completed. – Record retained indefinitely if return to duty is not completed. l

https: //clearinghouse. fmcsa. dot. gov/

https: //clearinghouse. fmcsa. dot. gov/

https: //clearinghouse. fmcsa. dot. gov

https: //clearinghouse. fmcsa. dot. gov/

Clearinghouse Results: January – September 2020 Drugs l l l l Alcohol Total Violations 39, 541 892 40, 433 Pre-employment 20, 949 27 20, 976 Random 13, 934 406 13, 340 Post Accident 1, 663 77 1, 740 Reasonable Suspicion 648 209 857 Return to Duty 466 7 473 Follow Up 817 25 842 Most Common Drugs Detected: Marijuana – 21, 016 Methamphetamine – 3, 803 Cocaine – 5, 889 Amphetamine – 3, 626 37, 617 - Drivers with at least 1 violation 34, 156 - Drivers in prohibited status.

FMCSA Medical Standards - Diabetes September 19, 2019 - FMCSA published new requirements concerning drivers with insulin-treated diabetes mellitus (ITDM). l Interstate drivers with ITDM are no longer required to obtain an exemption from FMCSA. l The treating clinician (TC), the healthcare professional who manages, and prescribes insulin for the treatment of the individual's diabetes, must provide an ITDM Assessment Form to the certified ME indicating that the individual maintains proper control of his or her diabetes. l Medical examiners may issue individuals with ITDM a Medical Certificate for up to a maximum of 12 months. l

https: //www. fmcsa. dot. gov/medical/driver-medicalrequirements/medical-applications-and-forms

https: //www. fmcsa. dot. gov/medical/driver-medicalrequirements/medical-applications-and-forms

https: //www. fmcsa. dot. gov/medical/drivermedical-requirements/medical-applicationsand-forms

Medical Programs Activities Planned for Early 2021 l Vision Standards - Notice of Proposed Rulemaking (NPRM) – Allow monocular vision drivers to operate without an exemption. l Revised Medical Handbook – Educational material that is more closely aligned with the regulations than the previous handbook. l Obstructive Sleep Apnea Bulletin – Update to the 2015 bulletin. l Medications Educational Material – Information for drivers and healthcare professionals about the risks of certain types of medications and combinations of medications.

http: //www. dot. gov/regulations/report-on-significant-rulemakings

https: //www. reginfo. gov/public/